Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

ICPBIO Starts Production at New Facility

Media Statement
20 November 2006


ICPBIO Starts Production at New Facility

* Plasma fractionation operations re-started on schedule in new plant

* Plans for bovine plasma processing to rise from two tonnes per week to up to 12 tonnes per week by January 2007

* New capacity will make ICPbio world’s largest chromatography processer of bovine plasma

Statement made by Dr Earl Stevens, Managing Director, ICP Biotechnology Limited

ICPbio is on schedule with its new manufacturing facility in Henderson, Waitakere City. Plasma fractionation operations restarted in the new factory over the weekend, as scheduled, following receipt of the required Government approvals late last week. The new facility will now operate 24 hours a day, seven days per week.

Initially the new plasma fractionation plant will process two tonnes a week of bovine plasma, and by late January 2007 the company plans to process up to 12 tonnes of bovine plasma per week.

Space freed up in the existing 26 Waipareira Avenue facility following the transfer of its plasma fractionation operations to the 37–39 Waipareira Avenue facility will be utilised for additional new biological products, to be extracted from other bovine tissues which are by-products of the New Zealand meat industry.

The 26 Waipareira Avenue facility continues to operate on a 12–16 hour per day, five to six day per week schedule, with the ability to also move to 24 hour a day operations as the business expands.

When operating closer to design capacity, the new manufacturing facility will make ICPbio the world’s largest chromatography fractionator (processor) of bovine plasma and position ICPbio to become the third largest producer of bovine albumin in the world.

Unlike other biotechnology companies, ICPbio’s success is not dependent on discovering and exploiting its own novel drug discovery intellectual property but instead focuses on the low risk, high return end of the biotechnology market – and adding significant value to NZ farming sector output. ICPbio manufactures the media, serums and biochemicals pharmaceutical and biotechnology companies use to make, test, store, and deliver their products.

ENDS

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Mycoplasma Bovis: More Properties Positive

One of the latest infected properties is in the Hastings district, the other three are within a farming enterprise in Winton. The suspect property is near Ashburton. More>>

ALSO:

Manawatū Gorge Alternative: More Work Needed To Choose Route

“We are currently working closely and in partnership with local councils and other stakeholders to make the right long-term decision. It’s vital we have strong support on the new route as it will represent a very significant long-term investment and it will need to serve the region and the country for decades to come.” More>>

ALSO:

RBNZ: Super Fund Chief To Be New Reserve Bank Governor

Adrian Orr has been appointed as Reserve Bank Governor effective from 27 March 2018, Finance Minister Grant Robertson says. More>>

ALSO:

ScoopPro: Helping PR Professionals Get More Out Of Scoop

Scoop.co.nz has been a fixture of New Zealand’s news and Public Relations infrastructure for over 18 years. However, without the financial assistance of those using Scoop in a professional context in key sectors such as Public Relations and media, Scoop will not be able to continue this service... More>>

Insurance: 2017 Worst Year On Record For Weather-Related Losses

The Insurance Council of New Zealand (ICNZ) announced today that 2017 has been the most expensive year on record for weather-related losses, with a total insured-losses value of more than $242 million. More>>

ALSO: